Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript May 7, 2025
Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.55.
Operator: Good afternoon, and welcome to the Quarter One 2025 Vanda Pharmaceuticals Incorporated Earnings Conference Call. I am Franz, and I will be the operator assisting you today. All lines have been placed on-mute to prevent any background noise. After the speakers’ remarks, there will be a...
